Literature DB >> 17998326

Cholangiocarcinoma and its management.

S A Khan1, A Miras, M Pelling, S D Taylor-Robinson.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17998326      PMCID: PMC2095716          DOI: 10.1136/gut.2007.138859

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  46 in total

1.  Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.

Authors:  T S Yeh; Y Y Jan; J H Tseng; C T Chiu; T C Chen; T L Hwang; M F Chen
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 2.  Imaging techniques in patients with biliary obstruction.

Authors:  A Cieszanowski; D Chomicka; M Andrzejewska; B Pruszyński; J Pawlak; A M Mustafa
Journal:  Med Sci Monit       Date:  2000 Nov-Dec

Review 3.  Treatment options for other hepatic malignancies.

Authors:  J G O'Grady
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

Review 4.  Early detection and treatment of cholangiocarcinoma.

Authors:  G J Gores
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

5.  Liver transplantation for cholangiocarcinoma: results in 207 patients.

Authors:  C G Meyer; I Penn; L James
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

6.  Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.

Authors:  I De Vreede; J L Steers; P A Burch; C B Rosen; L L Gunderson; M G Haddock; L Burgart; G J Gores
Journal:  Liver Transpl       Date:  2000-05       Impact factor: 5.799

7.  Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors.

Authors:  R E Hintze; H Abou-Rebyeh; A Adler; W Veltzke-Schlieker; R Felix; B Wiedenmann
Journal:  Gastrointest Endosc       Date:  2001-01       Impact factor: 9.427

Review 8.  Unknown primary tumours.

Authors:  H F Hillen
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

9.  Changing strategies in diagnosis and management of hilar cholangiocarcinoma.

Authors:  J Figueras; L Llado; C Valls; T Serrano; E Ramos; J Fabregat; A Rafecas; J Torras; E Jaurrieta
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

10.  Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.

Authors:  S H Zidi; F Prat; O Le Guen; Y Rondeau; G Pelletier
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

View more
  14 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

2.  Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

Authors:  Ke-Jun Zhang; Bing-Yuan Zhang; Kun-Peng Zhang; Li-Min Tang; Shi-Song Liu; Dong-Ming Zhu; Dian-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

3.  Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center.

Authors:  Ashwani K Singal; Jean-Nicolas Vauthey; James J Grady; John R Stroehlein
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-05       Impact factor: 4.553

Review 4.  Hilar cholangiocarcinoma: pathology and tumor biology.

Authors:  Dong Kuang; Guo-Ping Wang
Journal:  Front Med China       Date:  2010-11-25

Review 5.  Update on the management of cholangiocarcinoma.

Authors:  J R A Skipworth; M G Keane; S P Pereira
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

Review 6.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

7.  Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo.

Authors:  Youyou Qin; Wu Cui; Xuewei Yang; Baifeng Tong
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-15       Impact factor: 3.848

8.  Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.

Authors:  Chiara Braconi; Erica Swenson; Takayuki Kogure; Nianyuan Huang; Tushar Patel
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

9.  Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.

Authors:  Ruethairat Sriraksa; Constanze Zeller; Wei Dai; Afshan Siddiq; Andrew J Walley; Temduang Limpaiboon; Robert Brown
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-02

Review 10.  Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review.

Authors:  Geng Zhimin; Hidayatullah Noor; Zheng Jian-Bo; Wang Lin; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2013-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.